Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in ENLV — Enlivex Ltd.

CIK 1595888 NEW YORK, NY
Back to ENLV Full portfolio

Position in ENLV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$52,078 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
13 quarters on record

Common Shares in ENLV Over Time

Shares Held

Position Value (USD)

Derivatives in ENLV

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$22,660
PutShares
2,747

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in ENLV

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,660 41,200
2025-12-31 $52,078 74,082
2025-09-30 $22,390 21,529
2025-06-30 $68,377 61,052
2025-03-31 $78,336 80,759
2024-12-31 $15,061 12,873
2022-03-31 $293,514 52,507
2021-12-31 $173,125 27,700
2021-09-30 $109,282 11,061
2021-06-30 $93,663 10,524
2021-03-31 $122,766 11,070
2020-09-30 $64,193 10,807
2020-06-30 $155,397 30,711